Cold Plasma for Dental Restoration and Caries Prevention
NCT ID: NCT01529606
Last Updated: 2020-04-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2012-09-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enamel Remineralization Potential of Dentifrices in Situ
NCT01128946
Evaluation of Toothbrush Bristles in Plaque Reduction
NCT04681885
Development and Validation of a Multi-Mineral Fluoride Mouthrinse
NCT00642252
Non-Invasive Oral Biofilm Characterization
NCT02178046
Efficacy of Manual Toothbrushes in Removing Tooth Stains
NCT06486974
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care
Fifty patients will be recruited into standard treatment group and they will receive composite resin restoration for all decayed teeth and standard preventive treatment (cleaning and fluoride varnish application) at baseline.
Composite restoration and tooth cleaning
Standard preventive treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction.
Plasma treatment
Fifty patients will be recruited into plasma treatment group and they will receive plasma treatment after cavity preparation, composite resin restoration, standard preventive treatment followed by plasma treatment for non-carious teeth.
Plasma treatment
plasma treatment after preparation and for caries prevention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Composite restoration and tooth cleaning
Standard preventive treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction.
Plasma treatment
plasma treatment after preparation and for caries prevention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be generally healthy;
* be able to participate in the study;
* have no diagnosed periodontitis and pericoronitis;
* have no active mucosal diseases such as aphthous ulcers and herpetic stomatitis.
They must also agree to follow study instructions.
The patients must meet the following specific entry criteria:
* 1-5 untreated caries and at least one class II caries.
Exclusion Criteria
* no diagnosed cardiovascular diseases;
* no diagnosed immune-compromised diseases, such as HIV and AIDS;
* no other serious systemic diseases, such as cancer;
* no antibiotic therapy in the past 6 months;
* no use of non-steroidal anti-inflammatory drugs (NSAIDS) in the past 3 months; and
* no reported use of illicit drugs.
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
Nanova, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liang Hong
Associate Professor and Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liang Hong, DDS, Ph.D
Role: PRINCIPAL_INVESTIGATOR
The University of Tennessee Health Science Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Tennessee Health Science
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.